H1N1 Vaccine Update | Global Pandemics | H1N1 TREATMENT US

H1N1 Vaccine Update | Global Pandemics

November 23, 2009 — Jesse

With the scale of infection, it remains important that all antiviral treatment follow medical advice in order to reduce the development and spread of H1N1 anti-viral drug resistance. Dr Nikko Shindo, a Medical Officer in WHO’s Global …

Continue reading here:
H1N1 Vaccine Update | Global Pandemics

Posted in H1N1 Treatment. Tags: and-spread, anti-viral-drug, development, follow-medical, global, medical, medical-officer, nikko, nikko-shindo, reduce-the, reduce-the-development, remains-important, scale, the-scale, with-the-scale.

« Revised Peramivir IV renal dosing recommendations for H1N1 …

Health official answers readers’ questions on H1N1 (Zanesville Times Recorder) »